Main Article Content



The standard of care in non-resectable locally advanced head and neck cancer with squamous cell histology is radical radiotherapy (RT) along with concurrent chemotherapy. Previously, these patients were treated with conventional radiotherapy techniques. Such conventional techniques can lead to morbidity with an impact on quality-of-life (QOL) in long-term survivors. Conformal radiotherapy experiences significant improvements in QOL domains versus conventional techniques. Radiotherapy planning and treatment with conformal techniques require advanced and relatively expensive equipment. Our study is aimed at evaluating the feasibility of conventional radiotherapy techniques in terms of quality of life in locally advanced head and neck cancer patients in comparison to the conformal technique in the Indian setting.


Sixty patients with locally advanced head and neck cancer who received chemo-radiation therapy and came for follow-up after a minimum of two years were scheduled to complete the QOL questionnaire (QLQ-C30 and QLQ-H&N35 scores). These scores were compared between the patients who were treated with conventional and conformal techniques.


Results showed that when comparing EORTC QLQ–C30 scoring, patients who were treated with conventional RT had a significantly higher median score for emotional QOL and lower median scores for fatigue, pain, appetite loss, and financial difficulties as compared to the conformal RT group. But only the financial difficulties scale showed a significant p-value. When comparing EORTC QLQ–H&N35 scores, all QLQ-HN35 scores did not show any significant difference, except for speech problems. Patients treated with the conventional technique had a significantly lower median score for speech problems compared to the conformal RT group.


Based on these results, it is concluded that conventional radiotherapy techniques can be advised to locally advanced head and neck cancer patients when conformal radiotherapy techniques are not available, especially in developing or underdeveloped countries.


Quality-of-Life, Conventional Radiotherapy, Conformal Radiotherapy, Locally Advanced Head and Neck Cancer, QOL Questionnaire

Article Details

How to Cite
Akkineni Naga Prasanthi, Ashwini Gopal, Sukrutha Boggula, Heena Kauser, Vallurupalli Sudhakar Kumar, Deleep Kumar Gudipudi, & Alluri Krishnam Raju. (2022). Quality of Life in Locally Advanced Head and Neck Cancer Patients with Different Radiotherapy Techniques after Definitive Chemo Radiotherapy - A Real-World Data Study with Indian Patients. Journal of Evolution of Medical and Dental Sciences, 11(10), 824–828.


  1. Pignon JP, le Maitre A, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomized trials and 17,346 patients. Radiother Oncol 2009;92(1):4-14.
  2. Ge X, Liao Z, Yuan J, et al. Radiotherapy-related quality of life in patients with head and neck cancers: a meta-analysis. Support Care Cancer 2020;28(6):2701–12.
  3. Fang F, Tsai W, Chen H, et al. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma. Cancer 2007;109(2):313-21.
  4. Tribius S, Bergelt C. Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev 2011;37(7):511-9.
  5. Palazzi M, Orlandi E, Pignoli E, et al. Target coverage in head and neck cancer treated with intensity-modulated radiotherapy: a comparison between conventional and conformal techniques. Tumori Journal 2006;92(6):503-10.
  6. Aaronson NK, Ahmedzai S, Bergman B, et al. The european organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365-76.
  7. Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al. Development of a european organization for research and treatment of cancer (Eortc) questionnaire module to be used in quality of life assessments in head and neck cancer patients. Acta Oncol (Madr) 1994;33(8):879-85.
  8. Fayers P, Bottomley A. Quality of life research within the EORTC-the EORTC QLQ-C30. Eur J Cancer 2002;38 Suppl 4:125-33.
  9. Graff P, Lapeyre M, Desandes E, et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007;67(5):1309-17.
  10. Santos M, e-Silva LFO, Kohler H, et al. Health-related quality of life outcomes in head and neck cancer: results from a prospective, real-world data study with brazilian patients treated with intensity modulated radiation therapy, conformal and conventional radiation techniques. Int J Radiat Oncol Biol Phys 2021;109(2):485-94.
  11. Gupta T, Kannan S, Ghosh-Laskar S, et al. Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma. PLoS One 2018;13(7):e0200137.
  12. Nutting C, Morden J, Harrington K, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomized controlled trial. The Lancet Oncology 2011;12(2):127-36.